SCHEMBL10328686

SCHEMBL10328686

COC(=O)c1ncc(O)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.42
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA7 P43166 5/20 0.41
CA9 Q16790 5/20 0.41
CA14 Q9ULX7 5/20 0.41
XDH P47989 2/20 0.40
KDM4E B2RXH2 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
NFKB1 P19838 1/20 0.40
GFER P55789 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
FUT7 Q11130 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALPL P05186 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644695 0.84 NPSR1 (0.43) NPSR1XDHKDM4EL3MBTL1LMNA
SCHEMBL29738141 0.84 NPSR1 (0.43) NPSR1XDHKDM4EL3MBTL1LMNA
SCHEMBL15431711 0.82 ATM (0.47) NPSR1XDHKDM4EL3MBTL1LMNA
SCHEMBL28413248 0.81 CA12 (0.47) NPSR1CA12CA1CA2CA7
SCHEMBL30748264 0.81 CA12 (0.47) NPSR1CA12CA1CA2CA7
SCHEMBL15968597 0.81 CA12 (0.46) NPSR1CA12CA1CA2CA7
SCHEMBL14659730 0.81 NPSR1 (0.41) NPSR1XDHKDM4EL3MBTL1LMNA
SCHEMBL31231846 0.81 NPSR1 (0.41) NPSR1
SCHEMBL12248202 0.81 BACE1 (0.41) NPSR1CA1CA2KDM4ELMNA
SCHEMBL15543442 0.81 NPSR1 (0.41) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289814-A1 COMPOUNDS AS PARP1 INHIBITIORS NINGBO NEWBAY TECH DEVELOPMENT CO LTD (CN) 2025-09-18 US disclosed
CN-120058698-A Azetidine and pyrrolidine PARP1 inhibitors and uses thereof 新特拉有限公司 2025-05-30 CN disclosed
CN-118019532-B Azetidine and pyrrolidine PARP1 inhibitors and uses thereof 新特拉有限公司 2025-03-18 CN disclosed
EP-4514795-A1 COMPOUNDS AS PARP1 INHIBITIORS Ningbo Newbay Technology Development Co., Ltd (CN) 2025-03-05 EP disclosed
CN-119528804-A 2- { [2- (Phenoxymethyl) pyridin-5-yl ] oxy } ethanamine derivatives and related compounds as pest control agents, for example, for protecting plants 发现号收购集团 2025-02-28 CN disclosed
CN-119487027-A Compounds as PARP1 inhibitors 宁波新湾科技发展有限公司 2025-02-18 CN disclosed
CN-119285538-A 2- { [2- (Phenoxymethyl) pyridin-5-yl ] oxy } ethanamine derivatives and related compounds as pest control agents, for example, for protecting plants 发现号收购集团 2025-01-10 CN disclosed
EP-4408420-A1 AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF Xinthera, Inc. (US) 2024-08-07 EP disclosed
CN-118019532-A Azetidine and pyrrolidine PARP1 inhibitors and uses thereof 新特拉有限公司 2024-05-10 CN disclosed
US-20240109860-A1 HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2024-04-04 US disclosed
US-20140296221-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2014-10-02 US disclosed
US-20140296221-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2014-10-02 US disclosed
US-20140296222-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2014-10-02 US disclosed
US-20140206675-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2014-07-24 US disclosed
US-20140206675-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2014-07-24 US disclosed
US-8729071-B2 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use MERCK SHARP & DOHME CORP. (US) 2014-05-20 US disclosed
US-8729071-B2 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use MERCK SHARP & DOHME CORP. (US) 2014-05-20 US disclosed
US-20120183563-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE MERCK SHARP & DOHME LLC 2012-07-19 US disclosed
US-20120183563-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE MERCK SHARP & DOHME LLC 2012-07-19 US disclosed
WO-2011044181-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE SCHERING CORPORATION (US) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296221-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE BACE1, APP, BACE2 NPSR1 1353/4885CA12 2681/4885CA1 1037/4885
US-20250289814-A1 COMPOUNDS AS PARP1 INHIBITIORS PARP1, PARP11, PARP12 NPSR1 3960/4885CA12 4788/4885CA1 4826/4885
US-20120183563-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE BACE1, BACE2, APP NPSR1 1260/4885CA12 2722/4885CA1 821/4885
US-20140206675-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE BACE1, BACE2, APP NPSR1 1116/4885CA12 2503/4885CA1 729/4885
US-20240109860-A1 HETEROCYCLIC COMPOUNDS AS PESTICIDES DDT, CHRM1, ACHE NPSR1 551/4885CA12 4009/4885CA1 1468/4885
US-20140296222-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE BACE1, APP, BACE2 NPSR1 1353/4885CA12 2681/4885CA1 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.